Clinical Research: Phase 1 - Phase 4
PharmaTimes: Parkinson’s Disease and Gene Therapy – Strategic and Operational Considerations
The gene therapy era can be said to have begun in 1990, when the first gene therapy clinical trial took place. Some 3,000 clinical trials have followed that first study, a resounding affirmation of innovators’ increasing recognition of gene therapy’s breakthrough possibilities for treating a diverse range of disorders — especially afflictions with limited or...